[Home ] [Archive]   [ فارسی ]  
:: Main :: About us :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Advisory Board
Aims & Scope
Journal News
Articles archive::
All Issues
Current Issue
Articles in press
For Authors::
Submission Instruction
For Reviewers::
Reviewers Section
Subscription::
Subscription Form
News& Events::
Journal News
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
Top 10 contents
Inform others
Ethics & Permissions::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Indexing
                        
..
:: Volume 13, Issue 4 (Winter 2016) ::
Sci J Iran Blood Transfus Organ 2016, 13(4): 348-364 Back to browse issues page
A practical approach in laboratory diagnosis of Factor XIII deficiency
A. Dorgalaleh , Sh. Tabibian , Y. Farshi , M.S. Hosseini , M. Shams , B. Tavasoli , M. Shakouri , F. Roshan zamir
Keywords: Key words: Factor XIII Deficiency, Bleeding, Laboratory Diagnosis
Full-Text [PDF 576 kb]   (1694 Downloads)     |   Abstract (HTML)  (5621 Views)
Type of Study: Review Article | Subject: Hematology
Published: 2016/12/25
Full-Text:   (5999 Views)
References :  
  1. Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, et al. Factor XIII deficiency in Iran: a comprehensive review of the literature. Semin Thromb Hemost 2015; 41(3): 323-9.
  2. Dorgalaleh A, Rashidpanah J. Blood coagulation factor XIII and factor XIII deficiency. Blood Rev 2016; 30(6): 461-75.
  3. Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 2002; 100(3): 743-54.
  4. Dorgalaleh A, Naderi M, Shamsizadeh M. Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency. Ann Hematol 2016; 95(3): 451-5.
  5. Naderi  M,  Dorgalaleh  A,  Tabibian   S,   Alizadeh   S,
 
 
Eshghi P, Solaimani G. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol 2013; 3(4): 164-72.
  1. Dorgalaleh A, Kazemi A, Zaker F, Shamsizadeh M, Rashidpanah J, Mollaei M. Laboratory Diagnosis of Factor XIII Deficiency, Routine Coagulation Tests with Quantitative and Qualitative Methods. Clin Lab 2016; 62(4): 491-8.
  2. Dorgalaleh A, Tabibian S, Hosseini MS, Farshi Y, Roshanzamir F, Naderi M, et al. Diagnosis of factor XIII deficiency. Hematology 2016; 21(7): 430-9.
  3. Dorgalaleh A, Farshi Y, Alizadeh SH, Naderi M, Tabibian SH, Kazemi A, et al. Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran. J Thromb Haemost 2015; 13(9): 1735-6.
  4. Kohler HP, Ichinose A, Seitz R, Ariens RA, Muszbek L, Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 9(7): 1404-6.
  5. Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem 1973; 248(4): 1395-407.
  6. Dardik R, Loscalzo J, Inbal A. Factor XIII (FXIII) and angiogenesis. J Thromb Haemost 2006; 4(1): 19-25.
  7. Biswas A, Ivaskevicius V, Thomas A, Varvenne M, Brand B, Rott H, et al. Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Ann Hematol 2014; 93(10): 1665-76.
  8. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005; 93(6): 1101-7.
  9. Anwar R, Stewart AD, Miloszewski KJ, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995; 91(3): 728-35.
  10. Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona E. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011; 91(3): 931-72.
  11. Handrkova H, Schroeder V, Kohler H. The activation peptide of coagulation factor XIII is vital for its expression and stability. J Thromb Haemost 2015; 13(8): 1449-58.
  12. Schroeder V, Vuissoz J, Caflisch A, Kohler HP. Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thromb Haemost 2007; 97(6): 890-8.
  13. Kristiansen GK, Andersen MD. Reversible activation of cellular factor XIII by calcium. J Biol Chem 2011; 286(11): 9833-9.
  14. Lorand L. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 291-311.
  15. Bagoly Z, Katona E, Muszbek L. Factor XIII and inflammatory cells. Thromb Res 2012; 129 Suppl 2: S77-81.
  16. Kohler HP. Interaction between FXIII and fibrinogen. Blood 2013; 121(11): 1931-2.
  17. Korsan-Bengtsen K, Wilhelmsen L, Tibblin G. Blood coagulation and fibrinolysis in relation to degree of physical activity during work and leisure time. A study based on a random sample of 54-year-old men. Acta Med Scand 1973; 193(1-2): 73-7.
  18. Ghosh S, McEvoy P, McVerry BA. Idiopathic autoantibody that inhibits fibrin monomer polymerization. Br J Haematol 1983; 53(1): 65-72.
  19. Naderi M, Imani M, Eshghi P, Dorgalaleh A, Tabibian S, Alizadeh S, et al. Factor XIII deficiency in Sistan and Baluchistan province. Sci J Iran Blood Transfus Organ 2013; 10(3): 282-8. [Article in Farsi]
  20. Naderi M, Dorgalaleh A, Alizadeh S, Kashani Khatib Z, Tabibian S, Kazemi A, et al. Polymorphism of thrombin-activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency. Haemophilia 2014; 20(1): e89-92.
  21. Naderi M, Karimi M, Hosseini MS, Moradi EH, Shamsizadeh M, Dorgalaleh A. Long term follow up study on a large group of patients with congenital factor XIII deficiency treated prophylactically with Fibrogammin P®. Iran J Pharm Res 2016; 15(2): 635-40.
  22. Naderi M, Dorgalaleh A, Alizadeh S, Tabibian S, Hosseini S, Shamsizadeh M, et al. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency. Int J Hematol 2014; 100(5): 443-9.
  23. Dorgalaleh A, Tabibian S, Hosseini S, Shamsizadeh M. Guidelines for laboratory diagnosis of factor XIII deficiency. Blood Coagul Fibrinolysis 2016; 27(4): 361-4.
  24. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost 2009; 35(4): 426-38.
  25. Naderi M, Alizadeh S, Tabibian S, Hosseini S, Varmaghani B, Shamsizadeh M, et al. Effect of Social Factors on the Highest Global Incidence of Congenital Factor XIII Deficiency in Southeast of Iran. Arch Iran Med 2015; 18(5): 331.
  26. Schroeder V, Durrer D, Meili E, Schubiger G, Kohler HP. Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss Med Wkly 2007; 137(19-20): 272-8.
  27. Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M, et al. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 2013; 35(1): 1-13.
  28. Castellone D. How to deliver quality results in the coagulation laboratory: Commonly asked questions. Lab Med 2004; 35(4): 208-13.
  29. Cengiz M, Ulker P, Meiselman HJ, Baskurt OK. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythrocyte mechanical properties. Clin Chem Lab Med 2009; 47(6): 769-76.
  30. Kitchen S, McCraw A, Echenagucia M. Diagnosis of hemophilia and other bleeding disorders: A laboratory manual. 2nd ed. Canada: World Federation of Hemophilia; 2010. p. 34.
  31. Preston FE, Lippi G, Favaloro EJ, Jayandharan GR, Edison ES, Srivastava A. Quality issues in laboratory haemostasis. Haemophilia 2010; 16 Suppl 5: 93-9.
  32. Potgieter J, Pool R, Prinsloo A, Botha EM, Olorunju S. The impact of collection tube fill volume on international normalized ratio. Medical Technology SA 2011; 24(1): 11-6.
  33. Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost 2012; 38(6): 565-75.
  34. Lawrence  J.  Preanalytical variables in the coagulation
laboratory. Lab Med 2003; 34(1): 49-57.
  1. Narayanan S. Preanalytical aspects of coagulation testing. Haematologica 1995; 80(2 Suppl): 1-6.
  2. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med 2006; 130(2): 181-4.
  3. Salvagno GL, Lippi G, Montagnana M, Franchini M, Poli G, Guidi GC. Influence of temperature and time before centrifugation of specimens for routine coagulation testing. Int J Lab Hematol 2009; 31(4): 462-7.
  4. Jennings I, Kitchen S, Woods TA, Preston FE; UK NEQAS. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 2003; 1(12): 2603-8.
  5. Laki K, Lóránd L. On the Solubility of Fibrin Clots. Science 1948; 108(2802): 280.
  6. Lawrie A, Green L, Mackie I, Liesner R, Machin S, Peyvandi F. Factor XIII--an under diagnosed deficiency--are we using the right assays? J Thromb Haemost 2010; 8(11): 2478-82.
  7. Hsu P, Zantek ND, Meijer P, Hayward CP, Brody J, Zhang X, et al. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results. Semin Thromb Hemost 2014; 40(2): 232-8.
  8. Oertel K, Hunfeld A, Specker E, Reiff C, Seitz R, Pasternack R, et al. A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem 2007; 367(2): 152-8.
  9. Muszbek L, Katona E. Diagnosis and Management of Congenital and Acquired FXIII Deficiencies. Semin Thromb Hemost 2016; 42(4): 429-39.
  10. Song Y, Sheng D, Taubenfeld SM, Matsueda GR. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. Anal Biochem 1994; 223(1): 88-92.
  11. Kohler HP, Ariens RA, Whitaker P, Grant PJ. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998; 80(4):704.
  12. Nishida Y, Ikematsu S, Fukutake K, Fujimaki M, Fukutake K, Kakishita E. A new rapid and simple assay for factor XIII activity using dansylcadaverine incorporation and gel filtration. Thromb Res 1984; 36(2): 123-31.
  13. Dvilansky A, Britten AF, Loewy AG. Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility. Br J Haematol 1970; 18(4): 399-410.
  14. Miller CH, Platt SJ, Rice AS, Kelly F, Soucie JM;
    Hemophilia Inhibitor Research Study Investigators. Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance. J Thromb Haemost 2012; 10(6): 1055-61.
  15. Jang MA, Park YS, Lee KO, Kim HJ. Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency. Blood Coagul Fibrinolysis 2015; 26(1): 46-9.
  16. Biswas A, Ivaskevicius V, Thomas A, Varvenne M, Brand B, Rott H, et al. Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Ann Hematol  2014; 93(10): 1665-76.
  17. Borhany M, Handrkova H, Cairo A, Schroeder V, Fatima N, Naz A, et al. Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations. Haemophilia 2014; 20(4): 568-74.
  18. Katona E, Muszbek L, Devreese K, Kovacs KB, Bereczky Z, Jonkers M, et al. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations. Haemophilia 2014; 20(1): 114-20.
  19. Souri M, Biswas A, Misawa M, Omura H, Ichinose A. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines. Haemophilia 2014; 20(2): 255-62.
  20. Ivaskevicius V, Biswas A, Loreth R, Schroeder V, Ohlenforst S, Rott H, et al. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 2010; 16(4): 675-82.
  21. Naderi M, Reykande SE, Dorgalaleh A, Alizadeh S, Tabibian S, Einollahi N, et al. Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran. Blood Coagul Fibrinolysis 2016; 27(1): 97-100.
  22. Hosseini S, Dorgalaleh A, Bamedi T, Tavakol K, Tabibian S, Naderi M, et al. First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran. Blood Coagul Fibrinolysis 2015; 26(8): 908-11.
  23. Naderi M, Tabibian S, Menegatti M, Kalantar E, Kazemi A, Zaker F, et al. Disseminated intravascular coagulation with positive D-dimer: a controversial clinical feature in severe congenital factor XIII deficiency in southeast Iran. Blood Coagul Fibrinolysis 2016; 27(8): 933-5.
 
 
 
 
 
 
 
 


 
Review  Article
 

 
 
 
Sci J Iran Blood Transfus Organ 2017; 13(4): 348-364
 
A practical approach in laboratory diagnosis
of Factor XIII deficiency
 
Dorgalaleh A.1,  Tabibian Sh.1, Farshi Y.2, Hosseini M.S.3, Shams M.4, Tavasoli B.4,
Shakouri M.1, Roshan Zamir F.2
 
1Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran 
2School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
3School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4School of Allied Medical Sciences, Babol University of Medical Sciences, Babol, Iran
 
 
Abstract
Background and Objectives
Factor XIII (FXIII) deficiency is an extremely Rare Bleeding Disorder (RBD) with estimated incidence of 1 per 2 million in the general population. All routine coagulation tests including Bleeding Time (BT), Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and platelet count are normal in FXIII deficiency (FXIIID) and this makes the diagnosis of disorder difficult. In this study, we presented a practical approach for laboratory diagnosis of FXIIID.
 
Materials and Methods
For this review article, all relevant articles were searched using appropriate keywords.
 
Results
Clot solubility test is the most common diagnostic test of FXIIID that has low specificity and sensitivity and also can be affected by several factors including clotting and solubilizing agents. Although this test is not further recommended by experts for diagnosis of FXIID but due to expanded use of this method, it cannot be abolished and we can use it to screen the disease with some modifications. FXIII activity assay should be considered as a screening test of FXIIID. FXIII activity is performed by several methods among them photometric assay is the most common. Without a serum blank, photometric assay overestimates FXIII activity that in patients with severe FXIIID can be accompanied by life threatening bleeding.
 
Conclusions
FXIIID is a rare disease with lethal outcomes. A best clinical examination, family history as well as a suitable laboratory approach led to timely diagnosis of FXIIID and prevented misdiagnosis of the disease and the arising consequences. Thus, this study is to give a proper laboratory approach for diagnosis of FXIIID.
 
Key words: Factor XIII Deficiency, Bleeding, Laboratory Diagnosis
 
 
 
 
 
Received:  8 Jun 2015
Accepted: 9 Jul  2016
 
 
 

Correspondence: ِDorgalaleh A., PhD Student of Hematology & Blood Banking. Faculty of Allied Medicine, Iran University of Medical Sciences.
P.O.Box: 5983-14155, Tehran , Iran. Tel: (+9821) 8052234; Fax: (+9821) 80522963
E-mail:
1- Acridine Orange
1- Biological safety cabinet
1- Platelet Concentrate
2- Food and Drug Administration
3- Normal Skin Flora
4- Platelet Rich Plasma-Platelet Concentrate
5- Eosin-Methylene blue
6- Thioglycolate
 dorgalaleha@gmail.com
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Dorgalaleh A, Tabibian S, Farshi Y, Hosseini M, Shams M, Tavasoli B, et al . A practical approach in laboratory diagnosis of Factor XIII deficiency. Sci J Iran Blood Transfus Organ 2016; 13 (4) :348-364
URL: http://bloodjournal.ir/article-1-963-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 4 (Winter 2016) Back to browse issues page
فصلنامه پژوهشی خون Scientific Journal of Iran Blood Transfus Organ
The Scientific Journal of Iranian Blood Transfusion Organization - Copyright 2006 by IBTO
Persian site map - English site map - Created in 0.06 seconds with 39 queries by YEKTAWEB 4645